Observational studyBMC cardiovascular disorders2026
Preoperative platelet-related inflammatory burden is associated with delayed early hemodynamic recovery following minimally invasive cardiac surgery.
Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimally invasive cardiac surgery (MICS) is associated with reduced surgical trauma and improved postoperative recovery; however, early hemodynamic recovery remains variable and may be influenced by patient-related biological factors. This study evaluated the association between preoperative inflammatory biomarkers and delayed early postoperative recovery following MICS.
methodsThis retrospective observational study included 166 consecutive patients undergoing thoracotomy-based MICS at a single tertiary center between January 2020 and January 2026. Preoperative inflammatory indices, including platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII), were calculated from routine laboratory parameters. The primary endpoint was prolonged postoperative inotropic support (> 24 h); vasopressor-only therapy administered for vasoplegia or isolated blood pressure support was not counted. Multivariable complete-case logistic regression (n = 154), receiver operating characteristic (ROC) analysis, and sensitivity analyses were performed.
resultsProlonged inotropic support was needed in 41 patients (24.7%). Patients requiring prolonged support were older, had a higher prevalence of hypertension, and had longer cardiopulmonary bypass duration in univariable comparisons. LVEF was numerically lower but did not reach conventional statistical significance. PLR and SII were significantly higher in these patients (p = 0.003 and p = 0.010, respectively). In separate adjusted models, both PLR > = 142 and SII > = 462 were associated with prolonged support. In the combined complete-case model including both biomarkers, PLR > = 142 remained independently associated with prolonged support (OR 4.18, 95% CI 1.30-13.40, p = 0.016), whereas SII > = 462 did not (OR 1.66, 95% CI 0.52-5.31, p = 0.391). ROC analysis showed modest discrimination (PLR AUC 0.655, 95% CI 0.564-0.753, p = 0.003; SII AUC 0.634, 95% CI 0.538-0.729, p = 0.010). No significant associations were observed between inflammatory biomarkers and early mortality, acute kidney injury, or postoperative atrial fibrillation.
conclusionPreoperative platelet-related inflammatory burden, as reflected by PLR, was associated with delayed early postoperative hemodynamic recovery following MICS. However, the discriminatory performance of PLR was modest, and this biomarker should be interpreted as a complementary risk indicator rather than a stand-alone decision-making tool. These findings are exploratory and require prospective validation in independent cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.